Webinar: Canine CRP - Inflammation marker in plasma and serum

22. Sep 2025 | 2 min read

Webinar: Canine CRP - Inflammation marker in plasma and serum

Canine CRP Immunoassay

Gentian Canine CRP Immunoassay is an in vitro diagnostic test for quantitative determination of canine C-reactive protein (CRP) in dog serum and plasma, which has an important role in diagnosis and monitoring of inflammatory disorders in dogs.

The Product Manager for Canine CRP, Agnete Bratsberg, PhD, will go more into details about both CRP in dogs in general and the advantages of Gentian's immunoassay in this webinar.

 

Want to know more about Gentian’s Canine CRP immunoassay?

The biomarker CRP in general:

  • Canine CRP in the inflammation response
  • Canine CRP as reliable biomarker for diagnosis and monitoring of systemic inflammation

 

Gentian Canine CRP Immunoassay advantages:

  • A Particle-Enhanced Turbidimetric Immunoassay (PETIA) for in vitro diagnostic testing of canine CRP in dog plasma and serum sample
  • Canine-specific avian antibodies for high specificity and sensitivity
  • Fast and easy assay procedure
  • Available for a wide range of clinical analysers

Watch the webinar now

Join Product Manager Agnete Bratsberg Eriksen as she explains the role of CRP in detecting and monitoring inflammation, demonstrates how Gentian’s Canine CRP Immunoassay works in both plasma and serum, and shares practical tips for implementing it in your lab.

 

 

Get in touch to learn more

Want to learn more about the Gentian Canine CRP Immunoassay or explore how it fits into your lab workflow?

Reach out via the form below, or email us at marketing@gentian.com.

You may also read


GCAL® Customer Interview: Calprotectin in routine care across departments

Mar 30, 2026

GCAL® Customer Interview: Calprotectin in routine care across departments

From laboratory integration to clinical impact at Motol University Hospital Inflammation is rarely..

GCAL® Customer Story - 24/7 calprotectin testing in acute and chronic care

Mar 27, 2026

GCAL® Customer Story - 24/7 calprotectin testing in acute and chronic care

Enabling 24/7 circulating calprotectin testing in clinical practice

Calprotectin as a biomarker for immune dysfunction and 28‑day mortality in sepsis

Mar 26, 2026

Calprotectin as a biomarker for immune dysfunction and 28‑day mortality in sepsis

Circulating calprotectin: biomarker of immune dysfunction in sepsis - study results Results from a post-hoc..